13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC
SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 71 holding rows worth $445,291,323.
- Accession
- 0001420506-24-002416
- Filer
- CIK 1816307
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 71 entries on the cover page, a total value of $445,291,323 stated on the cover page (in dollars after the unit check, H1), rows summing to $445,291,323 with VALUE read as dollars as filed, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSilverArc Capital, LLC 028-20993
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NUVALENT INC COM | 670703107 | Stock | 371,441 | $37,998,414 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 635,439 | $31,746,532 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 347,695 | $25,381,735 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 475,555 | $21,842,241 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 6,946,488 | $18,963,912 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 639,840 | $18,357,010 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 470,565 | $16,018,033 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 255,578 | $13,389,731 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,221,362 | $13,190,710 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 167,110 | $12,227,439 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 744,592 | $11,906,026 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 901,129 | $11,444,338 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,099,490 | $11,269,773 | dollars as filed | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 3,687,548 | $10,546,387 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 348,866 | $10,036,875 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 35,774 | $9,838,923 | dollars as filed | |
| GERON CORP | 374163103 | COM | 1,801,561 | $8,179,087 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 378,746 | $7,290,861 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 60,500 | $6,913,335 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 574,558 | $6,653,382 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 146,657 | $6,599,565 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 1,147,891 | $6,542,979 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 51,245 | $6,399,988 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 3,561,094 | $6,338,747 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 1,645,808 | $6,270,528 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 1,795,080 | $5,654,502 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 5,645,352 | $5,568,575 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 455,082 | $5,433,679 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 513,369 | $5,364,655 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 461,660 | $5,318,323 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 627,552 | $5,145,926 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 103,862 | $5,103,779 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 99,566 | $4,975,313 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 145,000 | $4,928,550 | dollars as filed | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 124,353 | $4,144,685 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 19,940 | $3,865,170 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 67,045 | $3,857,769 | dollars as filed | |
| MODULAR MED INC | 60785L207 | COM NEW | 1,440,000 | $3,240,000 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 457,739 | $3,190,441 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 26,083 | $3,097,878 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 70,516 | $3,094,947 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,585,786 | $2,997,136 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 419,242 | $2,968,233 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 1,124,928 | $2,846,068 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 1,501,113 | $2,717,015 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 1,495,329 | $2,601,872 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 350,000 | $2,429,000 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 167,986 | $2,242,613 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 100,000 | $2,080,000 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 4,000,000 | $1,631,600 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 482,575 | $1,611,801 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 75,507 | $1,518,446 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 40,000 | $1,315,600 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 500,000 | $1,305,000 | dollars as filed | |
| EVOGENE LTD | M4119S187 | SHS NEW | 307,974 | $945,480 | dollars as filed | |
| MOLECULAR TEMPLATES INC | 608550208 | COM | 623,838 | $876,492 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 150,000 | $855,000 | dollars as filed | call |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 100,000 | $850,000 | dollars as filed | |
| VAXART INC NEW | 92243A200 | COM | 1,000,000 | $849,000 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 100,000 | $799,000 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 5,000 | $746,550 | dollars as filed | |
| Instil Bio Inc | 45783C200 | COM NEW | 10,517 | $708,004 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 92,298 | $683,005 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 558,466 | $463,527 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 100,000 | $435,000 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 166,666 | $421,665 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 17,800 | $367,214 | dollars as filed | call |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 168,300 | $318,087 | dollars as filed | call |
| ALIGOS THERAPEUTICS INC | 01626L204 | COM NEW | 26,219 | $227,057 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 76,784 | $144,354 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 104,828 | $6,761 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-002416 | this filing | 2024-11-14 | acceptance time not in the bulk data set |